4//SEC Filing
Rosenbaum David P. 4
Accession 0001628280-24-024951
CIK 0001437402other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:19 PM ET
Size
7.9 KB
Accession
0001628280-24-024951
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-05-21$7.81/sh−4,855$37,922→ 376,479 total - Sale
Common Stock
2024-05-21$7.81/sh−2,198$17,169→ 176,374 total(indirect: By Spouse)
Holdings
- 77,592(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Reflects the adjusted total which includes the purchase of 2,349 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
- [F3]Reflects the adjusted total which includes the purchase of 2,636 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
- [F4]The shares are directly held by the Reporting Person's wife.
- [F5]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
Documents
Issuer
ARDELYX, INC.
CIK 0001437402
Entity typeother
Related Parties
1- filerCIK 0001611311
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:19 PM ET
- Size
- 7.9 KB